MedPath

Effect of an immune-supportive diet on gut permeability and allergic symptoms in children with peanut and/or nut allergy.

Recruiting
Conditions
peanut and nut allergy
leaky gut
10018012
10001708
10014982
Registration Number
NL-OMON56415
Lead Sponsor
OLVG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
132
Inclusion Criteria

- Children of 3 - 18 years of age with a positive open or double-blind
placebo-controlled peanut or nut challenge < 24 months to inclusion;
OR
an obvious and objective IgE-mediated allergic reaction following the
consumption of isolated peanut or nut within 1 hours, confirmed by
sensitisation to peanut or nut < 24 months to inclusion;
- Children who are potty trained or house trained;
- Presence of specific IgE to peanut or a nut >=0.35 kU/l or skin prick test >
3 mm to peanut or nut, determined < 24 months prior to
challenge

Exclusion Criteria

- Only mild symptoms in the oral cavity to peanut or nut due to pollen food
syndrome;
- A negative peanut or nut challenge;
- Children who are not potty trained (house trained);
- Gastro-intestinal diseases (e.g. Morbus Crohn, celiac disease, Colitis
Ulcerosa), lactose-intolerance, severe cow's milk allergy
genetic syndromes, infectious/immunology diseases other than atopy, or
diabetes;
- Use of laxantia, such as lactulose;
- Not being able to read or write Dutch

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- Changes in small intestine permeability after 4 months of diet<br /><br>intervention as expressed by the Raffinose/Maltitol ratio (R/M ratio) in urine. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath